FAQs | CASAColumbia

FAQs about CASAColumbia and Yale's Collaboration

FAQs about Yale Collaboration

yale-faq

A.

Yes, we continue our work with Columbia University faculty and on collaborative research projects. We believe the relationship with Yale will strengthen our relationship with Columbia through long-standing collaborations that exist between Columbia and Yale psychiatry faculty within their respective Divisions of Substance Abuse and through NIDA’s National Drug Abuse Clinical Trials Network (CTN), in which the two universities have collaborated as long-standing regional research hubs. This is in addition to other affiliations, which include New York University, with whom CASAColumbia has begun working closely over the past year.

A.

The National Center on Addiction and Substance Abuse’s office will remain in midtown Manhattan and no staff will be moved to New Haven. New faculty and staff will work in New Haven and office space will be rented near the medical center, as necessary. As investigators and research staff in New York and New Haven begin collaborating on specific projects, each may spend time in the other office location as necessary to conduct policy, research or communication projects.

A.

In January 2016, CASAColumbia reverted to a shorter version of our former name: The National Center on Addiction and Substance Abuse. The “at Columbia University”  had become a source of confusion because not only are we not located near a Columbia campus,  but we are an independent non-profit organization with our own board of directors, senior leadership, and staff who are not Columbia employees. Confusion about our name increased in 2014 when we added Yale University, New York University, the City University of New York, and Northwell Health (formerly North Shore LIJ) to our group of scientific collaborators. Although we continue to collaborate with Columbia University on several projects, our board of directors and Columbia leaders mutually agreed that our identity should be clarified by removing the appearance of a controlling entity or exclusive academic partner from our business name.

Many people working in or writing about the substance use, abuse, and addiction field refer to us as CASA and that remains part of our logo. However, CASA is the registered acronym of the Court Appointed Special Advocates, and to avoid another area of name confusion, we prefer use of our full name, The National Center on Addiction and Substance Abuse, or “the Center."

A.

The National Center on Addiction and Substance Abuse is providing partial support for two senior psychiatry faculty at Yale, full support to junior faculty in public health and/or psychiatry and four research staff. In addition, a university-wide pilot studies program will support research and policy projects on addiction related topics. CASAColumbia will translate Yale research findings into information to be disseminated to the general public, policymakers and providers.

A.

In addition to facilitating The National Center on Addiction and Substance Abuse’s expanded work on behavioral addictions (gambling, food, sex, Internet), Yale has one of the foremost substance use and addiction research programs in the world. Its exceptional breadth and depth of expertise in addiction research, education and clinical programs will significantly expand the research base available for The National Center on Addiction and Substance Abuse to translate and disseminate findings to stakeholders and inform the public and health care policy. This furthers our mission: to connect science with policy and practice to better the lives of all people impacted by substance use and addiction.

Newsletter Additional Information

Newsletter Additional Information

Thank you for subscribing

This information will be used to better customize your experience and help inform future tools and features on our website.

Additional Information
WHICH ISSUES INTEREST YOU?
What brought you to our website?